Excerpts from the XVD scanner patent:“The current XV technique...

Excerpts from the XVD scanner patent:

“The current XV technique uniquely combines X-ray imaging with proprietary flow velocimetry algorithms to measure motion in all locations of the lung in fine spatial and temporal detail, enabling regional lung function measurements throughout the respiratory cycle, at every location within the lung.”

“Current XV technology is used in clinical applications via a Software as a Service (SaaS) model, whereby scans of the patient’s lungs are acquired using existing fluoroscopic X-ray equipment. The scans are then processed using software algorithms, via a cloud-based server, to provide functional imaging analysis of the patient’s lungs over time. However, the accuracy and quality of the XV analysis is limited by the images able to be acquired using existing medical scanners which require patients to remain still and breathe in a controlled fashion during scanning. This restricts access to many patient groups, including young children, the elderly, and patients with language, hearing or cognitive impairment, who are unable to be readily scanned due to positioning issues within the scanner and/or the inability to follow instructions for the scanning to be completed.”

“Due to ionizing radiation dose, use of X-ray based techniques (especially CT) for detection and treatment of various diseases, including acute respiratory disease, is severely restricted for vulnerable patients, such as infants and children who are more susceptible to tissue damage due to radiation. Furthermore, the inherent measurement limitations also severely restrict evidence- based detection and treatment of acute respiratory disease across all ages of patients.”